Frequently asked questions
The following questions are often asked by people contacting Retina UK.
Search
Search results
Our commitment to lived experience employment
In April 2022 we joined with another seven leading sight loss organisations to make a public commitment to increasing the number of blind and partially sighted people employed within our sector, including at senior management level.
Lottery
Do you want to win up to £25,000 and feel good about supporting people with inherited progressive sight loss?!
RECORDING: Annual Conference – 9 July 2022
A recording of the 45th Retina UK Annual Conference on 9 July 2022. The Conference was held at the Macdonald Burlington Hotel in Birmingham and also online.
Approaches to treatment
The development of a new treatment is a lengthy process, from early investigation of ideas and principles in the lab, through testing in cell and animal models to the final stages of clinical trials in human patients. The good news is that progress is increasingly rapid.
Webinar: Michael Gilhooley, Optogenetics
This session will introduce the technique of optogenetics and its potential for development into a treatment for IRDs.
Experimental therapy by Retina UK-funded researchers leads to ‘life changing improvements’
Researchers who received funding from Retina UK have carried out experimental gene therapy that is reported to have led to ‘life changing improvements’ to sight for four children with inherited sight loss.
School Fundraising
Download our School Fundraising Pack below to find out how you can raise money for Retina UK and have loads of fun in the process.
Volunteer Impact Report
Our volunteers are highly valued members of the Retina UK team and their roles are essential to help support and enable people affected by inherited sight loss to live fulfilling lives.
Meet a Researcher: Elena Piotter
Nurturing a new generation of scientists is a vital investment in the future of retinal disease research, so we are delighted to be funding, in collaboration with the Macular Society, a new PhD studentship at Oxford University, supervised by Professor Robert MacLaren.